Forecast & Rating4 analysts currently cover ImmunityBio, of which 4 give a positive rating. The average price target is $12.75, about 51.8% upside from the current price of $8.40. Coverage is limited, so the data is for reference only. Data as of Aug 4, 2026; this does not constitute investment advice.
Aug 4, 2026Price forecast
$12.7551.79%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met48.3%
Stock price$8.40
Avg. target$10.4
High target$24
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.